Ishares Biotechnology Etf Technical Analysis
| IBB Etf | USD 136.10 1.26 0.93% |
As of the 22nd of November, IShares Biotechnology retains the Market Risk Adjusted Performance of (0.13), risk adjusted performance of (0.08), and Standard Deviation of 1.11. IShares Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.
IShares Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as IShares, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ISharesIShares |
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
iShares Biotechnology ETF Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of iShares Biotechnology ETF volatility. High ATR values indicate high volatility, and low values indicate low volatility.
iShares Biotechnology ETF Trend Analysis
Use this graph to draw trend lines for iShares Biotechnology ETF. You can use it to identify possible trend reversals for IShares Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual IShares Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.IShares Biotechnology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for iShares Biotechnology ETF applied against its price change over selected period. The best fit line has a slop of 0.12 , which may imply that the returns on investment in iShares Biotechnology ETF will continue to fail. It has 122 observation points and a regression sum of squares at 512.74, which is the sum of squared deviations for the predicted IShares Biotechnology price change compared to its average price change.About IShares Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of iShares Biotechnology ETF on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of iShares Biotechnology ETF based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on iShares Biotechnology ETF price pattern first instead of the macroeconomic environment surrounding iShares Biotechnology ETF. By analyzing IShares Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of IShares Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to IShares Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
IShares Biotechnology November 22, 2024 Technical Indicators
Most technical analysis of IShares help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IShares from various momentum indicators to cycle indicators. When you analyze IShares charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 0.7868 | |||
| Coefficient Of Variation | (879.98) | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.24 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 6.56 | |||
| Value At Risk | (1.70) | |||
| Potential Upside | 1.55 | |||
| Skewness | (1.26) | |||
| Kurtosis | 3.72 |
iShares Biotechnology ETF One Year Return
Based on the recorded statements, iShares Biotechnology ETF has an One Year Return of 13.7%. This is 125.7% higher than that of the iShares family and 43.66% lower than that of the Health category. The one year return for all United States etfs is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.IShares Biotechnology November 22, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as IShares stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 28,544 | ||
| Daily Balance Of Power | 0.42 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 135.12 | ||
| Day Typical Price | 135.44 | ||
| Price Action Indicator | 1.61 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Biotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.